-
Personalized Medicine Powered by AI: Tailored Treatments Based on Genetics
Nurah Ekhlaque
July 24, 2025
Discover how AI is transforming personalized medicine by helping develop treatments tailored to an individual’s genetic profile. Explore its impact on drug discovery, patient care, and the future of pharma.
-
Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template
PharmaSources
May 10, 2024
Nucleic Acid Medicines Manufacture, Round 2 call.
-
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
PharmaSources
April 07, 2024
The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype DrivenVariant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.
-
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
B3C newswire
November 06, 2023
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK).
-
Adhering to Life's Simple 7 May Cut CHD Risk Despite Genetics
drugs.com
February 08, 2022
Ideal adherence to the American Heart Association (AHA) Life's Simple 7 (LS7) guidelines is associated with a lower lifetime risk for coronary heart disease (CHD)...
-
Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome
prnasia
December 03, 2021
In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins...
-
The Journal of Medicinal Chemistry Publishes Study Showing Potential of the Potent EED Inhibitor EEDi-5273 (APG-5918) to Achieve Complete Tumor Regression by Modulating the Epigenetics
prnasia
October 19, 2021
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a research team...
-
deCODE genetics - New study on inheritance and fetal growth
prnasia
July 20, 2021
In a paper published in Nature genetics, Scientists from deCODE genetics, a fully owned subsidiary of Amgen, report sequence variants that associate with birth weight and demonstrate how these variants affect birth weight through both the maternal and ...
-
deCODE genetics: Predicting the probability of death
prnasia
June 18, 2021
Scientists from deCODE genetics have developed a predictor based on protein measurements in blood samples that predicts the time to all-cause death better than traditional risk factors.
-
deCODE genetics - Rounding off the human genome
prnasia
May 11, 2021
In a study published , scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits.